Personalized mutation tracking could spot relapse sooner in bone marrow cancer patients
Knowledge-focused
Completed
This study looked at 308 people with myelodysplastic syndromes (MDS) who had a stem cell transplant. Researchers identified each patient's unique genetic mutations and then monitored those mutations in blood and bone marrow samples after transplant. The goal was to see if rising …
Sponsor: Nordic MDS Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC